Terpenes with Antitumor Activity: A Patent Review

Area of Science:

• Natural product chemistry
• Oncology
• Medicinal chemistry

Background:

• Cancer remains a leading global cause of death, with current treatments often having limited efficacy or severe side effects.
• Natural products, particularly terpenes, are being investigated as potential alternatives for cancer prevention and treatment due to their diverse biological activities.
• Terpenes exhibit documented anti-inflammatory, anti-tumorigenic, and hypolipidemic properties.

Purpose of the Study:

• To evaluate the development and application of terpenes and terpene-based formulations in novel cancer therapeutics.
• To assess the therapeutic potential of terpenes through a comprehensive patent review.

Main Methods:

• A patent review was conducted using specialized databases (WIPO, Espacenet).
• Patents were selected based on inclusion criteria, including pre-clinical and/or clinical trials and demonstrated anti-tumor effects.

Main Results:

• Eight patents were identified, with six originating from China and two from Japan.
• All reviewed patents confirmed substantial anti-tumor activity against various cancer cell types.
• Inventors emphasized the need for further pre-clinical and clinical studies to fully elucidate the therapeutic potential of these terpene products.

Conclusions:

• Natural products, including terpenes, represent a valuable resource for developing novel anti-cancer agents.
• Terpenes hold promise for synergistic effects in cancer treatment strategies.
• Further research and clinical trials are warranted to fully harness the anti-cancer potential of terpenes.